Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergistic anticancer effect of docosahexaenoic acid and isoliquiritigenin on human colorectal cancer cells through ROS-mediated regulation of the JNK and cytochrome c release
Hao Jin, Hak Sung Kim, Seung Taek Yu, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 2, pp. 1171-1180
Closed Access | Times Cited: 9

Showing 9 citing articles:

Chalcones and Gastrointestinal Cancers: Experimental Evidence
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 17
Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
Piao Luo, Qian Zhang, Shuo Shen, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100874-100874
Open Access | Times Cited: 17
The trojan horse strategy in T-ALL therapy by engineering T-ALL-derived exosomes for targeted delivery of Isoliquiritigenin to the bone marrow to conquer Drug-Resistant T-ALL in PDX model
Yong Liu, Lindi Li, Cheng Ouyang, et al.
Chemical Engineering Journal (2025), pp. 159379-159379
Open Access
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 33
The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials
Jaqueline de Freitas Rodrigues, Hellen Kempfer Philippsen, Maria Fâni Dolabela, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 2006-2006
Open Access | Times Cited: 9
ROS-Responsive PLGA-NPs for Co-Delivery of DTX and DHA for Colon Cancer Treatment
Roberta Cassano, Sonia Trombino, Federica Curcio, et al.
International Journal of Translational Medicine (2024) Vol. 4, Iss. 2, pp. 262-277
Open Access | Times Cited: 2
The Influence of APOE Genotype, DHA, and Flavanol Intervention on Brain DHA and Lipidomics Profile in Aged Transgenic Mice
Anneloes Martinsen, Rasha N.M. Saleh, Raphaël Chouinard‐Watkins, et al.
Nutrients (2023) Vol. 15, Iss. 9, pp. 2032-2032
Open Access | Times Cited: 4
Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway
Fenglin Luo, Yimeng Tang, Lin Zheng, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 43-43
Open Access | Times Cited: 4
Licoflavone A Suppresses Gastric Cancer Growth and Metastasis by Blocking the VEGFR-2 Signaling Pathway
Hongxia Gong, Xiaojie Jin, Guangxian Leng, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 5
Page 1

Scroll to top